145 related articles for article (PubMed ID: 21128686)
1. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation.
D'Aguanno S; D'Alessandro A; Pieroni L; Roveri A; Zaccarin M; Marzano V; De Canio M; Bernardini S; Federici G; Urbani A
J Proteome Res; 2011 Feb; 10(2):416-28. PubMed ID: 21128686
[TBL] [Abstract][Full Text] [Related]
2. Impact of cisplatin administration on protein expression levels in renal cell carcinoma: a proteomic analysis.
Vasko R; Mueller GA; von Jaschke AK; Asif AR; Dihazi H
Eur J Pharmacol; 2011 Nov; 670(1):50-7. PubMed ID: 21924258
[TBL] [Abstract][Full Text] [Related]
3. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.
Piskareva O; Harvey H; Nolan J; Conlon R; Alcock L; Buckley P; Dowling P; Henry M; O'Sullivan F; Bray I; Stallings RL
Cancer Lett; 2015 Aug; 364(2):142-55. PubMed ID: 25960282
[TBL] [Abstract][Full Text] [Related]
4. Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin.
D'Aguanno S; D'Agnano I; De Canio M; Rossi C; Bernardini S; Federici G; Urbani A
Mol Biosyst; 2012 Apr; 8(4):1068-77. PubMed ID: 22315092
[TBL] [Abstract][Full Text] [Related]
5. Acute application of cisplatin affects methylation status in neuroblastoma cells.
Tabata K; Sakai H; Nakajima R; Saya-Nishimura R; Motani K; Okano S; Shibata Y; Abiko Y; Suzuki T
Oncol Rep; 2011 Jun; 25(6):1655-60. PubMed ID: 21424131
[TBL] [Abstract][Full Text] [Related]
6. Use of proteomics to study chemosensitivity.
Poland J; Wandschneider S; Urbani A; Bernardini S; Federici G; Sinha P
Methods Mol Med; 2005; 111():267-81. PubMed ID: 15911985
[TBL] [Abstract][Full Text] [Related]
7. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
[TBL] [Abstract][Full Text] [Related]
8. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.
Le Moguen K; Lincet H; Deslandes E; Hubert-Roux M; Lange C; Poulain L; Gauduchon P; Baudin B
Proteomics; 2006 Oct; 6(19):5183-92. PubMed ID: 16941573
[TBL] [Abstract][Full Text] [Related]
10. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.
Sandoval JA; Eppstein AC; Hoelz DJ; Klein PJ; Linebarger JH; Turner KE; Rescorla FJ; Hickey RJ; Malkas LH; Schmidt CM
J Surg Res; 2006 Jul; 134(1):61-7. PubMed ID: 16650873
[TBL] [Abstract][Full Text] [Related]
12. Differential protein expression induced by transient transfection of metallothionein-3 gene in SH-SY5Y neuroblastoma cell line.
Zhou B; Yang W; Ji JG; Ru BG
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jun; 35(6):522-8. PubMed ID: 12796812
[TBL] [Abstract][Full Text] [Related]
13. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
14. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line.
Li SL; Ye F; Cai WJ; Hu HD; Hu P; Ren H; Zhu FF; Zhang DZ
J Cell Biochem; 2010 Mar; 109(4):625-33. PubMed ID: 20082317
[TBL] [Abstract][Full Text] [Related]
17. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
[TBL] [Abstract][Full Text] [Related]
18. A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.
Le Moguen K; Lincet H; Marcelo P; Lemoisson E; Heutte N; Duval M; Poulain L; Vinh J; Gauduchon P; Baudin B
Proteomics; 2007 Nov; 7(22):4090-101. PubMed ID: 17994630
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.
Garcia J; Faca V; Jarzembowski J; Zhang Q; Park J; Hanash S
J Proteome Res; 2009 Aug; 8(8):3791-6. PubMed ID: 19505085
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line.
Cimmino F; Spano D; Capasso M; Zambrano N; Russo R; Zollo M; Iolascon A
J Proteome Res; 2007 Jul; 6(7):2550-64. PubMed ID: 17559250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
